Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company ▾	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
TBPH	Theravance Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$107.46M	$105.89M	98.5%	35.7%	66.9%	$2.06
TXMD	TherapeuticsMD, Inc. Manufacturing · Year ended 2025-12-31 · USD	$3.02M	-$569.0K	-18.8%	-2.1%	71.6%	-$0.05
TPST	Tempest Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.26M	n/a	-393.9%	n/a	-$6.33
TELO	Telomir Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.41M	n/a	-176.1%	n/a	-$0.33
TNGX	Tango Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$62.38M	-$101.59M	-162.9%	-29.3%	48.3%	-$0.87
GCAN	Trafalgar International, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$331.6K	n/a	n/a	n/a	$0.00
TGTX	TG Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$616.29M	$447.18M	72.6%	69.0%	87.3%	$2.77
TEVA	Teva Pharmaceutical Industries Ltd Manufacturing · Year ended 2025-12-31 · USD	$17.26B	$1.41B	8.2%	17.8%	4.3%	$1.21
TENX	Tenax Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$52.60M	n/a	-54.2%	n/a	-$1.34
TLPH	Talphera, Inc. Manufacturing · Year ended 2025-12-31 · USD	$28.0K	-$14.29M	n/m	-83.9%	n/a	n/a
SNDX	Syndax Pharmaceuticals Inc Manufacturing · Year ended 2025-12-31 · USD	$172.35M	-$285.42M	-165.6%	-441.6%	627.8%	-$3.29
SBFM	Sunshine Biopharma Inc. Manufacturing · Year ended 2025-12-31 · USD	$36.31M	-$5.98M	-16.5%	-25.9%	4.1%	n/a
SMMT	Summit Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$1.08B	n/a	-163.9%	n/a	-$1.44
GPCR	Structure Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$141.20M	n/a	-9.3%	n/a	-$0.80
STOK	Stoke Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$184.42M	-$6.88M	-3.7%	-2.0%	404.5%	-$0.12
SYRE	Spyre Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$155.20M	n/a	-21.7%	n/a	n/a
SPRO	Spero Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$66.80M	$8.57M	12.8%	14.5%	39.2%	$0.15
SLGL	Sol-Gel Technologies Ltd. Manufacturing · Year ended 2025-12-31 · USD	$19.39M	-$6.13M	-31.6%	-26.9%	68.0%	-$2.19
SKYE	Skye Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$55.92M	n/a	-279.3%	n/a	-$1.41
SION	Sionna Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$75.27M	n/a	-24.5%	n/a	-$1.88
SILO	Silo Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$72.1K	-$4.23M	n/m	-67.0%	0.0%	-$0.50
SLN	Silence Therapeutics plc Manufacturing · Year ended 2025-12-31 · USD	$559.0K	-$88.61M	n/m	-142.2%	-98.7%	-$0.63
SHPH	Shuttle Pharmaceuticals Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$11.72M	n/a	-519.9%	n/a	-$7.16
STTK	Shattuck Labs, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.00M	-$48.81M	n/m	-59.2%	-82.5%	-$0.70
SER	Serina Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$130.0K	-$19.18M	n/m	n/a	132.1%	-$1.91

Rows per page: 2550 100